Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TreeMATAMPL and TreeMATA in Seasonal Allergic Rhinitis (Birch Pollen)
NCT00387478Phase 2Terminated
- Sponsor
- Allergy Therapeutics PLC
- Start
- Oct 2006
- Primary completion
- Jul 2007
- Modality
- Prophylactic Vaccines, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Tree MATA MPL in seasonal allergic rhinitis (SAR), sponsored by Allergy Therapeutics PLC. Started Oct 2006; status: terminated.
02
Drugs
Tree MATA MPL
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00387478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387478.